What Is Repatha and How Does It Compare to Lipitor?
Repatha (evolocumab) lowers LDL cholesterol by inhibiting PCSK9, a protein that reduces the liver's ability to clear LDL from blood. Lipitor (atorvastatin), a statin, blocks cholesterol production in the liver. Both treat high cholesterol but through different mechanisms—Repatha for patients intolerant to statins or needing extra LDL reduction alongside them.[1]
Common Side Effects of Repatha
Patients report:
- Nasopharyngitis (cold-like symptoms, 4-11%)
- Upper respiratory infections (5-8%)
- Flu (5-7%)
- Back pain (3-6%)
- Injection-site reactions (redness, pain; 5-7%)
- Joint pain (3-5%)
These occur in clinical trials like FOURIER, affecting 1-11% more than placebo.[2]
Common Side Effects of Lipitor
Typical issues include:
- Muscle pain (myalgia, 1-5%)
- Digestive problems (diarrhea, nausea, 2-5%)
- Headache (2-4%)
- Joint pain (1-3%)
Higher doses increase risks like elevated liver enzymes.[3]
Head-to-Head Side Effect Differences
Repatha shows fewer muscle-related issues than Lipitor—no significant myopathy or rhabdomyolysis in trials, unlike statins (0.3% risk with Lipitor). Injection-site reactions are Repatha-specific but mild and transient. Lipitor more often causes gastrointestinal upset and liver enzyme rises. In statin-intolerant patients switched to Repatha, muscle symptoms improved in 70-90%.[4][2]
| Side Effect Category | Repatha Frequency | Lipitor Frequency |
|----------------------|-------------------|-------------------|
| Muscle pain | Low (2-3%) | Moderate (1-5%) |
| GI issues | Rare (<2%) | Common (2-5%) |
| Injection reactions | Common (5-7%) | None |
| Infections | Common (4-11%) | Rare |
Serious Risks: What Patients Worry About Most
Repatha: Rare neurocognitive effects (confusion, 0.5-1%) or allergic reactions; no diabetes risk increase. Lipitor: Higher chance of new-onset diabetes (9% relative risk), severe muscle breakdown (rare, dose-dependent), and liver injury. Long-term data shows Repatha safer for muscle/liver in high-risk groups.[5][3]
Can You Use Them Together, and What Happens?
Combination is common and safe—Repatha boosts LDL drop by 50-60% on top of statins. Side effects don't compound significantly; trials report additive tolerability issues under 5%.[4]
Sources
[1]: FDA Repatha Label
[2]: FOURIER Trial, NEJM
[3]: FDA Lipitor Label
[4]: GAUSS-3 Trial, JAMA
[5]: PCSK9 Meta-Analysis, Lancet